ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Daclatasvir dihydrochloride
C40H52Cl2N8O6
811.8 g/mol
APIWarning

Daclatasvir dihydrochloride

CAS1009119-65-6
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material

Daclatasvir dihydrochloride is a complex organic compound used as an active pharmaceutical ingredient. It features a salt-like form with multiple aromatic rings and amide functional groups, and is provided as a research-grade material.

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 1009119-65-6

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

StrongSame Parent

Daclatasvir

CAS1009119-64-5

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.74

Ravidasvir

CAS1242087-93-9

pharmaceutical raw material

ReferenceSame Category

Vistusertib

CAS1009298-59-2

pharmaceutical raw material

ReferenceSame Category

Levofloxacin

CAS100986-85-4

pharmaceutical raw material

ReferenceSame Category

Pyridostigmine bromide

CAS101-26-8

pharmaceutical raw material

ReferenceSame Category

Hyoscyamine

CAS101-31-5

pharmaceutical raw material

Referencesame scaffold

Bis(2-methyl-2-propanyl) (2S,2'S)-2,2'-[4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl)]di(1-pyrrolidinecarboxylate)

CAS1007882-23-6

pharmaceutical intermediate

Referencesame scaffold

2-((2S)-Pyrrolidin-2-yl)-5-(4-(4-(2-((2S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)phenyl)-1himidazole tetrahydrochloride

CAS1009119-83-8

pharmaceutical intermediate

Safety Reference

Harmful
Harmful
Health Hazard
Health Hazard
Warning
H317May cause an allergic skin reaction
H319Causes serious eye irritation
H335May cause respiratory irritation
H373May cause damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name

methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;dihydrochloride

InChIKey

BVZLLUDATICXCI-JMSCDMLISA-N

SMILES

CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC.Cl.Cl

Synonyms (23)
  • Daclatasvir dihydrochloride (USAN)
  • BMS 790052 (di HClsalt)
  • BMS 790052-05
  • BMS-790052 dihydrochloride
  • Daclatasvir 2HCl
  • Daclatasvir Digydrochloride
  • Daclatasvir dihydrochloride
  • Daklinza
  • Daklinza (TN)
  • daclatasvir hydrochloride